C
Cellectricon
Cellectricon is a leading provider of advanced cell-based screening services to accelerate drug discovery
About Cellectricon
Cellectricon is a pioneering company in the field of neuroscience drug discovery, specializing in innovative in vitro research models. The company serves pharmaceutical and biotech firms, academic institutions, and research organizations. Operating in the global neuroscience market, Cellectricon employs a business model centered around providing high-value services and advanced technological solutions for early concept evaluation and transformative drug discovery campaigns. Revenue is generated through service contracts, collaborative research agreements, and licensing of their proprietary technology platform. The company is committed to staying at the forefront of scientific innovation by establishing a network of esteemed scientific experts to ensure the relevance and predictive power of their models.
Source: Dealroom company dataAt a glance
- Founded
- 2001
- Headquarters
- Mölndals kommun, Sweden
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Vinnova
Series A2 investors entered at this stage
Investor Growth Capital
Karolinska Development
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cellectricon on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cellectricon on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.